KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Minority Interest (2016 - 2026)

Abbott Laboratories' Minority Interest history spans 18 years, with the latest figure at $640.0 million for Q1 2026.

  • On a quarterly basis, Minority Interest rose 152.96% to $640.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $640.0 million, a 152.96% increase, with the full-year FY2025 number at $641.0 million, up 170.46% from a year prior.
  • Minority Interest hit $640.0 million in Q1 2026 for Abbott Laboratories, roughly flat from $641.0 million in the prior quarter.
  • Over the last five years, Minority Interest for ABT hit a ceiling of $641.0 million in Q4 2025 and a floor of $209.0 million in Q3 2022.
  • Historically, Minority Interest has averaged $283.8 million across 5 years, with a median of $232.0 million in 2024.
  • Biggest five-year swings in Minority Interest: dropped 3.48% in 2023 and later soared 170.46% in 2025.
  • Tracing ABT's Minority Interest over 5 years: stood at $219.0 million in 2022, then rose by 2.28% to $224.0 million in 2023, then grew by 5.8% to $237.0 million in 2024, then soared by 170.46% to $641.0 million in 2025, then decreased by 0.16% to $640.0 million in 2026.
  • Business Quant data shows Minority Interest for ABT at $640.0 million in Q1 2026, $641.0 million in Q4 2025, and $310.0 million in Q3 2025.